Clark Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,798
Closed -$261K 501
2025
Q3
$261K Buy
5,798
+660
+13% +$30.8K ﹤0.01% 411
2025
Q2
$238K Sell
5,138
-946,005
-99% -$46.4M ﹤0.01% 396
2025
Q1
$58M Buy
951,143
+8,085
+0.9% +$471K 0.42% 76
2024
Q4
$53.3M Buy
943,058
+105,340
+13% +$5.89M 0.37% 85
2024
Q3
$43.3M Buy
837,718
+830,040
+10,811% +$38.9M 0.3% 104
2024
Q2
$319K Sell
7,678
-112
-1% -$5.01K ﹤0.01% 347
2024
Q1
$422K Sell
7,790
-5,535
-42% -$282K ﹤0.01% 337
2023
Q4
$684K Sell
13,325
-1,592
-11% -$83.6K 0.01% 299
2023
Q3
$866K Sell
14,917
-1,519
-9% -$93.1K 0.01% 265
2023
Q2
$1.05M Sell
16,436
-4,037
-20% -$271K 0.01% 255
2023
Q1
$1.42M Buy
20,473
+200
+1% +$14.1K 0.02% 240
2022
Q4
$1.46M Sell
20,273
-3,608
-15% -$272K 0.01% 237
2022
Q3
$1.7M Sell
23,881
-344,784
-94% -$25M 0.02% 217
2022
Q2
$28.4M Buy
368,665
+23,050
+7% +$1.76M 0.37% 74
2022
Q1
$25.2M Buy
345,615
+325,193
+1,592% +$21.8M 0.28% 127
2021
Q4
$1.27M Sell
20,422
-445
-2% -$26.1K 0.02% 240
2021
Q3
$1.24M Sell
20,867
-778
-4% -$51.2K 0.02% 246
2021
Q2
$1.45M Sell
21,645
-703,603
-97% -$45.9M 0.02% 252
2021
Q1
$45.8M Sell
725,248
-40,643
-5% -$2.53M 0.7% 33
2020
Q4
$47.5M Sell
765,891
-30,087
-4% -$1.85M 0.78% 26
2020
Q3
$48M Sell
795,978
-178,333
-18% -$10.7M 0.9% 20
2020
Q2
$57.3M Sell
974,311
-42,136
-4% -$2.52M 1.07% 12
2020
Q1
$56.7M Sell
1,016,447
-246,452
-20% -$15.1M 1.44% 12
2019
Q4
$81.1M Buy
1,262,899
+448,807
+55% +$25.7M 1.7% 9
2019
Q3
$41.3M Sell
814,092
-355,544
-30% -$16.7M 0.94% 31
2019
Q2
$53M Sell
1,169,636
-6,538
-0.6% -$305K 1.12% 18
2019
Q1
$56.1M Buy
1,176,174
+703,116
+149% +$35M 1.34% 14
2018
Q4
$24.6M Buy
473,058
+19,631
+4% +$1.05M 0.66% 58
2018
Q3
$28.1M Buy
453,427
+426,734
+1,599% +$25.3M 0.71% 49
2018
Q2
$1.48M Sell
26,693
-2,015
-7% -$109K 0.04% 182
2018
Q1
$1.82M Sell
28,708
-3,710
-11% -$239K 0.06% 177
2017
Q4
$1.99M Buy
32,418
+9,237
+40% +$578K 0.06% 161
2017
Q3
$1.48M Sell
23,181
-1,032
-4% -$60.3K 0.05% 196
2017
Q2
$1.35M Buy
24,213
+7,525
+45% +$409K 0.05% 184
2017
Q1
$907K Sell
16,688
-526
-3% -$28.9K 0.04% 209
2016
Q4
$1.01M Hold
17,214
0.05% 209
2016
Q3
$928K Sell
17,214
-265
-2% -$17K 0.05% 218
2016
Q2
$1.29M Sell
17,479
-122,471
-88% -$8.65M 0.08% 177
2016
Q1
$8.94M Sell
139,950
-5,958
-4% -$376K 0.69% 55
2015
Q4
$10M Buy
145,908
+72,339
+98% +$4.78M 0.81% 33
2015
Q3
$4.36M Buy
73,569
+57,726
+364% +$3.66M 0.39% 75
2015
Q2
$1.05M Buy
15,843
+17
+0.1% +$1.12K 0.1% 173
2015
Q1
$1.02M Hold
15,826
0.09% 177
2014
Q4
$934K Sell
15,826
-300
-2% -$16.9K 0.09% 143
2014
Q3
$825K Hold
16,126
0.07% 142
2014
Q2
$782K Sell
16,126
-300
-2% -$14.8K 0.07% 147
2014
Q1
$853K Hold
16,426
0.07% 147
2013
Q4
$873K Sell
16,426
-250
-1% -$12.7K 0.07% 142
2013
Q3
$772K Sell
16,676
-150
-0.9% -$6.58K 0.06% 152
2013
Q2
$752K Buy
+16,826
New +$730K 0.07% 148

Other funds holding BMY

Clark Capital Management Group's BMY Position: Q4 2025 in Review

Clark Capital Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 5,798 shares — an estimated $261K sold.

Clark Capital Management Group first reported a position in BMY in Q2 2013 and held it in 50 quarters. The position peaked at $81.1M in Q4 2019. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Clark Capital Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Clark Capital Management Group sold 5,798 Bristol-Myers Squibb shares in Q4 2025, an estimated $261K.
  • Clark Capital Management Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 50 quarters.
  • Clark Capital Management Group's Bristol-Myers Squibb position peaked at $81.1M in Q4 2019.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Clark Capital Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.